BOULDER, Colo., July 25, 2019 /PRNewswire/ -- DreamWave, renowned developers of luxury full-body shiatsu massage chairs, today announced that the DreamWave R.6 will debut at the L

IRVINE, Calif., July 25, 2019 /PRNewswire/ -- Kelley Blue Book was honored with the St. Jude Children's Hospital Partner Campaign of the Year Award for its 2018 "Turn Your Car into Good Karma" partnership with Charitable Adult Rides & Services (CARS).

BOCA RATON, Fla., July 25, 2019 /PRNewswire/ -- The CBD industry in the United States is exploding ever since Congress at the end of last year removed most of the roadblocks to selling CBD- and hemp-related products. Today, you can buy CBD beauty products and CBD supplements, to name just a few of the products that are being marketed with

BOCA RATON, Fla., July 25, 2019 /PRNewswire/ -- SynTech Nutrition, a leading European nutritional supplement company, is getting behind 

PALO ALTO, Calif. and STOCKHOLM, July 25, 2019 /PRNewswire/ -- Varian (NYSE: VAR) announced that the Karolinska University Hospital Solna in Sweden is the first hospital in Scandinavia to deliver High Dose Rate (HDR) brachytherapy treatments using the new Bravos™ afterloader system. B

KRAKOW, Poland, July 25, 2019 /PRNewswire/ -- Selvita, S.A. (WSE: SLV), a leading clinical stage drug discovery company committed to developing innovative medicines for treatment of patients with cancer, announced today the appointment of Setareh Shamsili, M.D., Ph.D., to the role of Chief Medical Officer. A seasoned veteran, Dr. Sha

INDIANAPOLIS, July 24, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment of severe hypoglycemia in people with diabetes ages four years and above, Eli Lilly and Company (NYSE: LLY) announced today. BAQSIMI is the first and only nasally administered glucagon, and it was designed

SAN FRANCISCO, July 24, 2019 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in Karyopharm Therapeutics Inc.'s (NASDAQ: KPTI) April 28, 2017 and May 7, 2018 public offerings to the firm's investigation into possible securities law violations.

MENLO PARK, Calif., July 24, 2019 /PRNewswire/ -- Drawbridge Health, a healthcare technology company streamlining the blood draw process for both patients and healthcare providers, today announced it has completed a strategic international financing.  New investors Sumitomo Dainippon Pharma and Mitsubishi UFJ Capital were joined by current investors GE Ventures

SUZHOU, China, July 24, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality innovative medicines for the treatment of oncology, autoimmune and other major diseases, today announced that the first patient has been dosed in ORIENT-31, a trial th